N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide

C95H97N31O7 — CID 158060288

IUPACN-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide
SMILESCc1cncc(-c2cccc(C(=O)Nc3cn(C)nc3-c3ccc(N4CCN(C)CC4)cn3)n2)c1.Cc1cncc(-c2cccc(C(=O)Nc3cn(C)nc3-c3ccc(N4CCOCC4)cn3)n2)c1.Cn1cc(NC(=O)c2cccc(-c3ccn[nH]3)n2)c(-c2ccc(N3CCOCC3)cn2)n1.Cn1cc(NC(=O)c2cccc(-c3cn[nH]c3)n2)c(-c2ccc(N3CCOCC3)cn2)n1
InChIInChI=1S/C26H28N8O.C25H25N7O2.2C22H22N8O2/c1-18-13-19(15-27-14-18)21-5-4-6-23(29-21)26(35)30-24-17-33(3)31-25(24)22-8-7-20(16-28-22)34-11-9-32(2)10-12-34;1-17-12-18(14-26-13-17)20-4-3-5-22(28-20)25(33)29-23-16-31(2)30-24(23)21-7-6-19(15-27-21)32-8-10-34-11-9-32;1-29-14-20(27-22(31)19-4-2-3-17(26-19)15-11-24-25-12-15)21(28-29)18-6-5-16(13-23-18)30-7-9-32-10-8-30;1-29-14-20(26-22(31)19-4-2-3-16(25-19)17-7-8-24-27-17)21(28-29)18-6-5-15(13-23-18)30-9-11-32-12-10-30/h4-8,13-17H,9-12H2,1-3H3,(H,30,35);3-7,12-16H,8-11H2,1-2H3,(H,29,33);2-6,11-14H,7-10H2,1H3,(H,24,25)(H,27,31);2-8,13-14H,9-12H2,1H3,(H,24,27)(H,26,31)
InChIKeyFKOBWZAICGFBCN-UHFFFAOYSA-N
MW1785.03 g/mol
LogP11.30
Rot. Bonds20

About N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide

N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide (PubChem CID 158060288) has the molecular formula C95H97N31O7 and a molecular weight of 1785.03 g/mol. Its IUPAC name is N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide
PubChem CID158060288
Molecular FormulaC95H97N31O7
Molecular Weight1785.03 g/mol
Exact Mass1783.82
IUPAC NameN-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide
SMILESCc1cncc(-c2cccc(C(=O)Nc3cn(C)nc3-c3ccc(N4CCN(C)CC4)cn3)n2)c1.Cc1cncc(-c2cccc(C(=O)Nc3cn(C)nc3-c3ccc(N4CCOCC4)cn3)n2)c1.Cn1cc(NC(=O)c2cccc(-c3ccn[nH]3)n2)c(-c2ccc(N3CCOCC3)cn2)n1.Cn1cc(NC(=O)c2cccc(-c3cn[nH]c3)n2)c(-c2ccc(N3CCOCC3)cn2)n1
InChIInChI=1S/C26H28N8O.C25H25N7O2.2C22H22N8O2/c1-18-13-19(15-27-14-18)21-5-4-6-23(29-21)26(35)30-24-17-33(3)31-25(24)22-8-7-20(16-28-22)34-11-9-32(2)10-12-34;1-17-12-18(14-26-13-17)20-4-3-5-22(28-20)25(33)29-23-16-31(2)30-24(23)21-7-6-19(15-27-21)32-8-10-34-11-9-32;1-29-14-20(27-22(31)19-4-2-3-17(26-19)15-11-24-25-12-15)21(28-29)18-6-5-16(13-23-18)30-7-9-32-10-8-30;1-29-14-20(26-22(31)19-4-2-3-16(25-19)17-7-8-24-27-17)21(28-29)18-6-5-15(13-23-18)30-9-11-32-12-10-30/h4-8,13-17H,9-12H2,1-3H3,(H,30,35);3-7,12-16H,8-11H2,1-2H3,(H,29,33);2-6,11-14H,7-10H2,1H3,(H,24,25)(H,27,31);2-8,13-14H,9-12H2,1H3,(H,24,27)(H,26,31)
InChIKeyFKOBWZAICGFBCN-UHFFFAOYSA-N
XLogP11.30
TPSA417.83 Ų
H-Bond Donors6
H-Bond Acceptors32
Rotatable Bonds20
Heavy Atoms133
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001785.03
LogP ≤ 511.30
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1032

Analyze N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide?
The IUPAC name of N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide (CID 158060288) is N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide.
What is the SMILES notation for N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide?
The canonical SMILES for N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide is Cc1cncc(-c2cccc(C(=O)Nc3cn(C)nc3-c3ccc(N4CCN(C)CC4)cn3)n2)c1.Cc1cncc(-c2cccc(C(=O)Nc3cn(C)nc3-c3ccc(N4CCOCC4)cn3)n2)c1.Cn1cc(NC(=O)c2cccc(-c3ccn[nH]3)n2)c(-c2ccc(N3CCOCC3)cn2)n1.Cn1cc(NC(=O)c2cccc(-c3cn[nH]c3)n2)c(-c2ccc(N3CCOCC3)cn2)n1.
What is the InChIKey of N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide?
The InChIKey is FKOBWZAICGFBCN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28N8O.C25H25N7O2.2C22H22N8O2/c1-18-13-19(15-27-14-18)21-5-4-6-23(29-21)26(35)30-24-17-33(3)31-25(24)22-8-7-20(16-28-22)34-11-9-32(2)10-12-34;1-17-12-18(14-26-13-17)20-4-3-5-22(28-20)25(33)29-23-16-31(2)30-24(23)21-7-6-19(15-27-21)32-8-10-34-11-9-32;1-29-14-20(27-22(31)19-4-2-3-17(26-19)15-11-24-25-12-15)21(28-29)18-6-5-16(13-23-18)30-7-9-32-10-8-30;1-29-14-20(26-22(31)19-4-2-3-16(25-19)17-7-8-24-27-17)21(28-29)18-6-5-15(13-23-18)30-9-11-32-12-10-30/h4-8,13-17H,9-12H2,1-3H3,(H,30,35);3-7,12-16H,8-11H2,1-2H3,(H,29,33);2-6,11-14H,7-10H2,1H3,(H,24,25)(H,27,31);2-8,13-14H,9-12H2,1H3,(H,24,27)(H,26,31).
What are the key properties of N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide?
N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide has a molecular weight of 1785.03 g/mol, XLogP of 11.30, 20 rotatable bonds, 6 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-methyl-3-[5-(4-methylpiperazin-1-yl)-2-pyridinyl]pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(5-methyl-3-pyridinyl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-4-yl)pyridine-2-carboxamide;N-[1-methyl-3-(5-morpholin-4-yl-2-pyridinyl)pyrazol-4-yl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide is sourced from PubChem (CID 158060288), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).